An embodiment includes a shape memory polymer (SMP) foam with visibility under both X-ray and magnetic resonance imaging (MRI) modalities. Dual modality visibility is achieved by chemically incorporating monomers with X-ray visible iodine-motifs and MRI visible monomers with gadolinium content. This material platform has the potential to be used in a variety of medical devices.

An embodiment includes a shape memory polymer (SMP) foam with visibility under both X-ray and magnetic resonance imaging (MRI) modalities. Dual modality visibility is achieved by chemically incorporating monomers with X-ray visible iodine-motifs and MRI visible monomers with gadolinium content. This material platform has the potential to be used in a variety of medical devices.

Platinum-nickel-based ternary or higher alloys include platinum at about 65-80 wt. %, nickel at about 18-27 wt. %, and about 2-8 wt. % of ternary or higher additions that may include one or more of Ir, Pd, Rh, Ru, Nb, Mo, Re, W, and/or Ta. These alloys are age-hardenable, provide hardness greater than 580 Knoop, ultimate tensile strength in excess of 320 ksi, and elongation to failure of at least 1.5%. The alloys may be used in static and moveable electrical contact and probe applications. The alloys may also be used in medical devices.

Devices for removing clot material from a blood vessel lumen and associated systems and methods are disclosed herein. A clot retrieving device may include, for example, an elongated shaft, a capture structure, a cover, and a connector coupled to the distal zone of elongated shaft. The connector may include an inner band and an outer band. The inner band may at least partially surround the distal zone of the elongated shaft and a portion of the proximal region of the capture structure, and the outer band may at least partially surround the inner band. In some embodiments, the first end portion of the cover may be secured between the inner band and the outer band.

Devices for removing clot material from a blood vessel lumen and associated systems and methods are disclosed herein. A clot retrieving device may include, for example, an elongated shaft, a capture structure, a cover, and a connector coupled to the distal zone of elongated shaft. The connector may include an inner band and an outer band. The inner band may at least partially surround the distal zone of the elongated shaft and a portion of the proximal region of the capture structure, and the outer band may at least partially surround the inner band. In some embodiments, the first end portion of the cover may be secured between the inner band and the outer band.

Embodiments are directed to radiopaque implantable structures (e.g., stents) formed of cobalt-based alloys that comprise cobalt, chromium, tungsten, and nickel. Tungsten is present above its solubility limit (about 15%), but is still only present as a super-saturated, primarily single-phase material exhibiting an FCC microcrystalline structure.

Embodiments are directed to radiopaque implantable structures (e.g., stents) formed of cobalt-based alloys that comprise cobalt, chromium, tungsten, and nickel. Tungsten is present above its solubility limit (about 15%), but is still only present as a super-saturated, primarily single-phase material exhibiting an FCC microcrystalline structure.

A method for forming a porous implant suitable for a cavity from which tissue has been removed includes incorporating a gas or a pore forming agent into an alginate solution; transferring the alginate solution with the gas or the pore forming agent into a solidified body mold having a desired shape with an outer surface; removing the water from the solidified body; and subjecting the solidified body to a conversion solution to convert the outer surface to a less soluble alginate creating a composition comprising the outer surface having less soluble alginate and a core having more soluble alginate.

A method for forming a porous implant suitable for a cavity from which tissue has been removed includes incorporating a gas or a pore forming agent into an alginate solution; transferring the alginate solution with the gas or the pore forming agent into a solidified body mold having a desired shape with an outer surface; removing the water from the solidified body; and subjecting the solidified body to a conversion solution to convert the outer surface to a less soluble alginate creating a composition comprising the outer surface having less soluble alginate and a core having more soluble alginate.

The invention relates to a medical device, in particular a stent, having a radially self-expandable lattice structure (10) which is tubular at least in some sections and which is made of a single wire (11), which is interwoven with itself and which comprises a core material (11a) which is visible under X-ray and a superelastic jacket material (11b) and forms meshes (12) of the lattice structure (10). The invention is characterised in that a plurality of meshes (12) arranged directly adjacently in the circumferential direction of the lattice structure (10) form a mesh ring (13), and the lattice structure (10), in a fully self-expanded state, has an expansion diameter D.sub.exp, the mesh ring (13) having a mesh number n, and the core material (11a) having a core diameter d.sub.Kern, and the following being true for the core diameter d.sub.Kern: d.sub.Kern=f.Math.(D.sub.exp/n), with the following being true for a visibility factor f: 0.05≤f≤0.08.